Treatment with transthyretin-lowering RNA interference therapeutics is not associated with ocular or other clinical events due to vitamin A reduction: pooled analysis of vutrisiran and patisiran data
11 May 2026 (10:30 - 11:15)
Organised by: 
About the speaker
Columbia University Irving Medical Centre, New York (United States of America)
6 More presentations in this session
Doctor M. Antunez-Ballesteros (Coruna, A, ES)
Doctor P. Debonnaire (Brugge, BE)
Doctor P. Monteiro (Porto, PT)
Access the full session
The Event
Heart Failure 2026
11 May 2026
10:30 CET
You may be interested in
Congress Session
